Tomáš Kazda

1.5k total citations
101 papers, 1000 citations indexed

About

Tomáš Kazda is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Tomáš Kazda has authored 101 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 37 papers in Genetics and 30 papers in Oncology. Recurrent topics in Tomáš Kazda's work include Glioma Diagnosis and Treatment (35 papers), Brain Metastases and Treatment (23 papers) and Advanced Radiotherapy Techniques (12 papers). Tomáš Kazda is often cited by papers focused on Glioma Diagnosis and Treatment (35 papers), Brain Metastases and Treatment (23 papers) and Advanced Radiotherapy Techniques (12 papers). Tomáš Kazda collaborates with scholars based in Czechia, United States and Slovakia. Tomáš Kazda's co-authors include Pavel Šlampa, Radim Jančálek, Petr Pospíšil, Petr Burkoň, M Slavík, Martin Bulik, Ondřej Slabý, Radek Lakomý, Martin Smrčka and Tomáš Procházka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Tomáš Kazda

87 papers receiving 983 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomáš Kazda Czechia 16 434 388 259 222 189 101 1000
Pavel Šlampa Czechia 15 403 0.9× 340 0.9× 227 0.9× 184 0.8× 197 1.0× 92 916
Robert Nordal Canada 14 330 0.8× 413 1.1× 181 0.7× 193 0.9× 88 0.5× 27 825
Tu Dan United States 15 182 0.4× 309 0.8× 151 0.6× 191 0.9× 190 1.0× 52 749
Franziska Eckert Germany 23 304 0.7× 449 1.2× 281 1.1× 528 2.4× 182 1.0× 95 1.5k
Valérie Panet-Raymond Canada 16 474 1.1× 414 1.1× 215 0.8× 306 1.4× 220 1.2× 50 1.4k
Ya-Yu Tsai United States 17 357 0.8× 555 1.4× 111 0.4× 411 1.9× 125 0.7× 72 1.0k
Walter Curran United States 5 738 1.7× 404 1.0× 213 0.8× 117 0.5× 195 1.0× 8 940
Matthew M. Grabowski United States 14 683 1.6× 244 0.6× 176 0.7× 276 1.2× 113 0.6× 36 1.1k
Stefania Scarpino Italy 20 379 0.9× 277 0.7× 150 0.6× 355 1.6× 205 1.1× 50 1.4k
Guillaume Vogin France 17 133 0.3× 368 0.9× 272 1.1× 227 1.0× 125 0.7× 61 851

Countries citing papers authored by Tomáš Kazda

Since Specialization
Citations

This map shows the geographic impact of Tomáš Kazda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Kazda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Kazda more than expected).

Fields of papers citing papers by Tomáš Kazda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomáš Kazda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Kazda. The network helps show where Tomáš Kazda may publish in the future.

Co-authorship network of co-authors of Tomáš Kazda

This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Kazda. A scholar is included among the top collaborators of Tomáš Kazda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Kazda. Tomáš Kazda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Izadi, Nasim, P. Solar, Alemeh Zamani, et al.. (2025). Breaking boundaries: role of the brain barriers in metastatic process. Fluids and Barriers of the CNS. 22(1). 3–3. 12 indexed citations
2.
Burkoň, Petr, Iveta Selingerová, Oldřich Coufal, et al.. (2025). Quality of life in early breast cancer patients after adjuvant accelerated partial-breast irradiation (APBI) in randomized trial. Scientific Reports. 15(1). 1387–1387.
4.
Preusser, Matthias, Tomáš Kazda, Émilie Le Rhun, et al.. (2024). Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study. Trials. 25(1). 366–366. 6 indexed citations
5.
Burkoň, Petr, Iveta Selingerová, M Slavík, et al.. (2024). Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study. Radiation Oncology. 19(1). 17–17. 2 indexed citations
6.
Hendrych, Michal, P. Solar, Markéta Hermanová, et al.. (2023). Spinal Metastasis in a Patient with Supratentorial Glioblastoma with Primitive Neuronal Component: A Case Report with Clinical and Molecular Evaluation. Diagnostics. 13(2). 181–181. 4 indexed citations
7.
Kalita, Ondřej, Tomáš Kazda, Radim Jančálek, et al.. (2023). Effects of Reoperation Timing on Survival among Recurrent Glioblastoma Patients: A Retrospective Multicentric Descriptive Study. Cancers. 15(9). 2530–2530. 7 indexed citations
8.
Halámková, Jana, Tomáš Kazda, Dagmar Adámková Krákorová, et al.. (2023). The risk of second primary malignancies in colorectal cancer patients using calcium channel blockers. Scientific Reports. 13(1). 3490–3490. 1 indexed citations
10.
Slavík, M, et al.. (2020). The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma. Journal of Oral Pathology and Medicine. 49(9). 886–896. 15 indexed citations
11.
Burkoň, Petr, et al.. (2020). Stereotactic Body Radiotherapy of Lymph Node Oligometastases. Klinicka onkologie. 33(2). 114–122. 5 indexed citations
12.
Kazda, Tomáš, Radek Lakomý, Petr Pospíšil, et al.. (2019). Current approaches to the radiotherapy of brain metastases from solid tumors. 13(4). 167–172. 1 indexed citations
13.
Kazda, Tomáš, Petr Burkoň, Petr Pospíšil, et al.. (2018). Radiotherapy of glioblastoma 15 years after the landmark Stupp’s trial: more controversies than standards?. Radiology and Oncology. 52(2). 121–128. 45 indexed citations
14.
Slavík, M, Markéta Hermanová, Jiří Šáňa, et al.. (2018). Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition. Journal of Oral Pathology and Medicine. 47(9). 864–872. 5 indexed citations
15.
Němeček, Radim, Lenka Radová, Tomáš Kazda, et al.. (2016). Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy. SHILAP Revista de lepidopterología. 2 indexed citations
16.
Pospíšil, Petr, Tomáš Kazda, Pavel Šlampa, & Radim Jančálek. (2016). Current strategy for treatment of high-grade gliomas. Neurologie pro praxi. 17(5). 287–292.
17.
Němeček, Radim, Lenka Radová, Tomáš Kazda, et al.. (2016). Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy. OncoTargets and Therapy. Volume 9. 4695–4703. 15 indexed citations
18.
Kazda, Tomáš, et al.. (2016). PET/CT in giant cell arteritis: High 18F-FDG uptake in the temporal, occipital and vertebral arteries. Revista Española de Medicina Nuclear e Imagen Molecular. 35(6). 398–401. 5 indexed citations
19.
Kazda, Tomáš, Petr Pospíšil, Petr Burkoň, et al.. (2015). Utilization of Prognostic Indexes for Patients with Brain Metastases in Daily Radiotherapy Routine – is the Complexity and Intricacy Still an Issue?. Klinicka onkologie. 28(5). 352–358. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026